{"id":"https://openalex.org/W2804959633","doi":"https://doi.org/10.1097/cmr.0000000000000458","title":"Early onset of diffuse melanosis cutis under pembrolizumab therapy illustrates the limitations of anti-PD-1 checkpoint inhibitors","display_name":"Early onset of diffuse melanosis cutis under pembrolizumab therapy illustrates the limitations of anti-PD-1 checkpoint inhibitors","alternate_titles":[],"publication_year":2018,"publication_date":"2018-05-17","ids":{"openalex":"https://openalex.org/W2804959633","doi":"https://doi.org/10.1097/cmr.0000000000000458","mag":"2804959633","pmid":"https://pubmed.ncbi.nlm.nih.gov/29781871"},"language":"en","primary_location":{"id":"doi:10.1097/cmr.0000000000000458","doi":"https://doi.org/10.1097/cmr.0000000000000458","is_oa":false,"landing_page_url":"https://doi.org/10.1097/cmr.0000000000000458","pdf_url":null,"source":{"id":"https://openalex.org/S3207524","display_name":"Melanoma Research","issn_l":"0960-8931","issn":["0960-8931","1473-5636"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Melanoma Research","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2804959633"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5075754000","display_name":"Alexander Thiem","orcid":"https://orcid.org/0000-0001-9504-4281","observed_orcids":["https://orcid.org/0000-0001-9504-4281"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Alexander Thiem","raw_affiliation_strings":["Department of Dermatology, Venereology and Allergology","fax: +49 931 201 26700"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, Venereology and Allergology","institution_ids":[]},{"raw_affiliation_string":"fax: +49 931 201 26700","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079528427","display_name":"Patrick Schummer","orcid":"https://orcid.org/0000-0001-9836-0933","observed_orcids":["https://orcid.org/0000-0001-9836-0933"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Patrick Schummer","raw_affiliation_strings":["Department of Dermatology, Venereology and Allergology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, Venereology and Allergology","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007990150","display_name":"Simon Ueberschaar","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Simon Ueberschaar","raw_affiliation_strings":["Department of Dermatology, Venereology and Allergology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, Venereology and Allergology","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019937386","display_name":"Andreas Kerstan","orcid":"https://orcid.org/0000-0001-6483-0191","observed_orcids":["https://orcid.org/0000-0001-6483-0191"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andreas Kerstan","raw_affiliation_strings":["Department of Dermatology, Venereology and Allergology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, Venereology and Allergology","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102831149","display_name":"Hermann Kneitz","orcid":"https://orcid.org/0000-0002-5604-0357","observed_orcids":["https://orcid.org/0000-0002-5604-0357"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hermann Kneitz","raw_affiliation_strings":["Department of Dermatology, Venereology and Allergology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, Venereology and Allergology","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005332655","display_name":"David Schrama","orcid":"https://orcid.org/0000-0002-6931-8194","observed_orcids":["https://orcid.org/0000-0002-6931-8194"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David Schrama","raw_affiliation_strings":["Department of Dermatology, Venereology and Allergology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, Venereology and Allergology","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079059898","display_name":"Silke Appenzeller","orcid":"https://orcid.org/0000-0002-5472-8692","observed_orcids":["https://orcid.org/0000-0002-5472-8692"]},"institutions":[{"id":"https://openalex.org/I4210100919","display_name":"Comprehensive Cancer Center Mainfranken","ror":"https://ror.org/013tmk464","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I25974101","https://openalex.org/I4210100919","https://openalex.org/I4210126310"]},{"id":"https://openalex.org/I4210126310","display_name":"Universit\u00e4tsklinikum W\u00fcrzburg","ror":"https://ror.org/03pvr2g57","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210126310"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Silke Appenzeller","raw_affiliation_strings":["Comprehensive Cancer Center Mainfranken, University Hospital W\u00fcrzburg"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Comprehensive Cancer Center Mainfranken, University Hospital W\u00fcrzburg","institution_ids":["https://openalex.org/I4210100919","https://openalex.org/I4210126310"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056044576","display_name":"Svenja Meierjohann","orcid":"https://orcid.org/0000-0002-9058-7196","observed_orcids":["https://orcid.org/0000-0002-9058-7196"]},"institutions":[{"id":"https://openalex.org/I25974101","display_name":"University of W\u00fcrzburg","ror":"https://ror.org/00fbnyb24","country_code":"DE","type":"education","lineage":["https://openalex.org/I25974101"]},{"id":"https://openalex.org/I4210100919","display_name":"Comprehensive Cancer Center Mainfranken","ror":"https://ror.org/013tmk464","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I25974101","https://openalex.org/I4210100919","https://openalex.org/I4210126310"]},{"id":"https://openalex.org/I4210126310","display_name":"Universit\u00e4tsklinikum W\u00fcrzburg","ror":"https://ror.org/03pvr2g57","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210126310"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Svenja Meierjohann","raw_affiliation_strings":["Comprehensive Cancer Center Mainfranken, University Hospital W\u00fcrzburg","Department of Physiological Chemistry, University of W\u00fcrzburg, W\u00fcrzburg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Comprehensive Cancer Center Mainfranken, University Hospital W\u00fcrzburg","institution_ids":["https://openalex.org/I4210100919","https://openalex.org/I4210126310"]},{"raw_affiliation_string":"Department of Physiological Chemistry, University of W\u00fcrzburg, W\u00fcrzburg, Germany","institution_ids":["https://openalex.org/I25974101"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008750058","display_name":"Bastian Schilling","orcid":"https://orcid.org/0000-0001-8859-4103","observed_orcids":["https://orcid.org/0000-0001-8859-4103"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bastian Schilling","raw_affiliation_strings":["Department of Dermatology, Venereology and Allergology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, Venereology and Allergology","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076078511","display_name":"Matthias Goebeler","orcid":"https://orcid.org/0000-0001-7095-9848","observed_orcids":["https://orcid.org/0000-0001-7095-9848"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Matthias Goebeler","raw_affiliation_strings":["Department of Dermatology, Venereology and Allergology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, Venereology and Allergology","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5017486762","display_name":"Anja Gesierich","orcid":"https://orcid.org/0009-0003-7129-3699","observed_orcids":["https://orcid.org/0009-0003-7129-3699"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anja Gesierich","raw_affiliation_strings":["Department of Dermatology, Venereology and Allergology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, Venereology and Allergology","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5075754000"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.4067,"has_fulltext":false,"cited_by_count":8,"citation_normalized_percentile":{"value":0.61813144,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"28","issue":"5","first_page":"465","last_page":"468"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10392","display_name":"Cutaneous Melanoma Detection and Management","score":0.0010999999940395355,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pembrolizumab","display_name":"pembrolizumab","score":0.9940000176429749},{"id":"https://openalex.org/keywords/pd-1-inhibitors","display_name":"PD-1 inhibitors","score":0.8690000176429749},{"id":"https://openalex.org/keywords/melanuria","display_name":"melanuria","score":0.8579999804496765},{"id":"https://openalex.org/keywords/liver-metastases","display_name":"liver metastasis","score":0.7139999866485596},{"id":"https://openalex.org/keywords/immune-related-adverse-events","display_name":"immune-related adverse events","score":0.6690000295639038},{"id":"https://openalex.org/keywords/treatment-response-prediction","display_name":"treatment response prediction","score":0.6370000243186951},{"id":"https://openalex.org/keywords/elderly-patients","display_name":"elderly patients","score":0.6240000128746033},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.375}],"concepts":[{"id":"https://openalex.org/C2780057760","wikidata":"https://www.wikidata.org/wiki/Q13896859","display_name":"Pembrolizumab","level":4,"score":0.9797440767288208},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8970159888267517},{"id":"https://openalex.org/C2776494729","wikidata":"https://www.wikidata.org/wiki/Q1848900","display_name":"Contraindication","level":3,"score":0.6533660292625427},{"id":"https://openalex.org/C2780030458","wikidata":"https://www.wikidata.org/wiki/Q7041828","display_name":"Nivolumab","level":4,"score":0.6434802412986755},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5256717801094055},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.47787705063819885},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.4768596589565277},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.46237680315971375},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4338306188583374},{"id":"https://openalex.org/C2778934254","wikidata":"https://www.wikidata.org/wiki/Q5196857","display_name":"Cutis","level":2,"score":0.41940760612487793},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.24043169617652893},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.19688427448272705},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.12047436833381653},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000074322","descriptor_name":"Antineoplastic Agents, Immunological","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000074322","descriptor_name":"Antineoplastic Agents, Immunological","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008548","descriptor_name":"Melanosis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008548","descriptor_name":"Melanosis","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D012878","descriptor_name":"Skin Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012878","descriptor_name":"Skin Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1097/cmr.0000000000000458","doi":"https://doi.org/10.1097/cmr.0000000000000458","is_oa":false,"landing_page_url":"https://doi.org/10.1097/cmr.0000000000000458","pdf_url":null,"source":{"id":"https://openalex.org/S3207524","display_name":"Melanoma Research","issn_l":"0960-8931","issn":["0960-8931","1473-5636"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Melanoma Research","raw_type":"journal-article"},{"id":"pmid:29781871","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/29781871","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Melanoma research","raw_type":"Case Reports"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Case Report","id":"https://openalex.org/study-designs/case-report"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":14,"referenced_works":["https://openalex.org/W1945499801","https://openalex.org/W1976029345","https://openalex.org/W1979959397","https://openalex.org/W2050084613","https://openalex.org/W2051828880","https://openalex.org/W2074391357","https://openalex.org/W2152897456","https://openalex.org/W2258373335","https://openalex.org/W2415365877","https://openalex.org/W2588081028","https://openalex.org/W2596627582","https://openalex.org/W2615188404","https://openalex.org/W2740797355","https://openalex.org/W3024260239"],"related_works":["https://openalex.org/W2581893032","https://openalex.org/W4318927018","https://openalex.org/W2588081028","https://openalex.org/W2917990354","https://openalex.org/W2759283067","https://openalex.org/W2970926394","https://openalex.org/W4205501164","https://openalex.org/W2897833123","https://openalex.org/W2842194621","https://openalex.org/W2805354919"],"abstract_inverted_index":{"Anti-PD-1":[0],"targeted":[1,181],"immunotherapies":[2],"have":[3,18,97],"revolutionized":[4],"the":[5,34,64,146],"treatment":[6,177],"of":[7,28,36,74,88,110,123,138],"advanced":[8,51],"melanoma":[9,54],"and":[10,14,45,55,80,114],"other":[11],"tumor":[12,112],"entities,":[13],"long":[15],"disease-free":[16],"intervals":[17],"been":[19,98],"reported":[20,99,156],"in":[21,172],"responding":[22],"patients.":[23],"However,":[24],"a":[25,130,135,169],"considerable":[26],"number":[27],"patients":[29,77,116,174],"still":[30],"progress":[31],"rapidly":[32],"after":[33,121,157],"start":[35],"anti-PD-1":[37,141],"antibodies.":[38],"Here,":[39],"we":[40],"document":[41],"two":[42,72],"patients,":[43],"78":[44],"85-year":[46],"old,":[47],"who":[48],"suffered":[49],"from":[50],"BRAF-V600":[52],"wild-type":[53],"received":[56],"pembrolizumab":[57],"2":[58,119],"mg/kg":[59],"every":[60],"3":[61],"weeks":[62],"as":[63],"first":[65],"systemic":[66],"treatment.":[67,142],"After":[68],"only":[69],"one,":[70],"respectively,":[71],"infusions":[73],"pembrolizumab,":[75],"both":[76,115],"developed":[78],"melanuria":[79],"diffuse":[81],"melanosis":[82],"cutis":[83],"(DMC)":[84],"on":[85],"sun-exposed":[86],"areas":[87],"their":[89],"skin.":[90],"Both":[91],"also":[92],"had":[93],"liver":[94],"metastases,":[95],"which":[96,150],"to":[100,140,145,162],"be":[101,134,163,168],"associated":[102],"with":[103],"DMC":[104,128,173],"before.":[105],"Pembrolizumab":[106],"was":[107],"stopped":[108],"because":[109],"rapid":[111],"progression":[113],"died":[117],"within":[118],"months":[120],"manifestation":[122],"DMC.":[124],"We":[125],"conclude":[126],"that":[127,132,155,179],"is":[129,151,180,183],"condition":[131],"may":[133,167],"negative":[136],"predictor":[137],"response":[139],"With":[143],"respect":[144],"very":[147],"short":[148],"survival,":[149],"even":[152],"shorter":[153],"than":[154],"conventional":[158],"therapies,":[159],"it":[160],"needs":[161],"evaluated":[164],"whether":[165],"immunotherapy":[166],"(relative)":[170],"contraindication":[171],"when":[175],"another":[176],"option,":[178],"therapy,":[182],"available.":[184]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2804959633","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":3},{"year":2019,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2018-06-01T00:00:00"}
